Growth Flags
show if company had growth for consecutive years
| Older periods | Dec '20 | Feb '21 | Jun '21 | Dec '21 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | — | 0.00 | 0.00 |
P/S ratio |
0.00 | — | 1,323.42 | 697.71 | |
P/FCF ratio |
0.00 | — | 0.00 | 0.00 | |
P/Operating CF |
(6.29) | — | (106.61) | (51.89) | |
P/B ratio |
4.36 | — | 30.86 | 31.35 | |
Price to Tangible BV |
8.87 | — | 47.29 | 76.45 | |
EV/Sales |
0.00 | — | 1,302.08 | 692.37 | |
EV/EBITDA |
0.00 | — | 0.00 | 0.00 | |
EV/Operating CF |
(3.57) | — | (23.99) | (10.96) | |
EV/FCF |
(3.57) | — | (23.58) | (10.81) | |
Quick Ratio |
1.97 | 1.97 | 4.18 | 4.71 | |
Current Ratio |
2.45 | 2.45 | 4.22 | 5.21 | |
Net Debt/EBITDA |
0.31 | 0.31 | 1.60 | 0.42 | |
Debt/Assets |
2.22% | 2.22% | 1.96% | 23.13% | |
Debt/Equity |
0.03 | 0.03 | 0.02 | 0.43 | |
Asset Turnover |
0.00 | 0.00 | 0.03 | 0.04 | |
Operating CF/Net income |
0.90 | 0.90 | 0.21 | (9.41) | |
Capex/Depreciation |
(0.15) | (0.13) | (0.22) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | — | — | |
Research and Development Expense of Revenue |
3,715.44% | — | 4,100.87% | 3,298.97% | |
Selling, General and Administrative Expense of Revenue |
0.00% | — | 0.00% | 1,314.78% | |
Intangible Assets out of Total Assets |
0.40 | 0.40 | 0.29 | 0.32 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.06 | — | 0.02 | 0.01 | |
Graham Number |
0.00 | — | 0.00 | 0.00 | |
Earnings Yield |
(3.97%) | — | (7.29%) | (12.34%) | |
Free Cash Flow Yield |
(26.23%) | — | (4.17%) | (9.18%) | |
Revenue per Share |
0.00 | — | 0.00 | 0.00 | |
Operating CF per Share |
(1.90) | 0.00 | (0.10) | (0.10) | |
Capex per Share |
(0.02) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.91) | 0.00 | (0.10) | (0.10) | |
Cash per Share |
0.84 | 0.00 | 0.18 | 0.12 | |
Shareholders Equity per Share |
2.73 | 0.00 | 0.35 | 0.17 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.73 | 0.00 | 0.35 | 0.17 | |
Free Cash Flow |
(27.29) | (27.16) | (16.21) | (18.94) | |
Working Capital |
12.34 | 12.34 | 31.69 | 27.84 | |
Capital Expenditures |
(0.23) | (0.21) | (0.16) | (0.12) | |
Net Current Asset Value |
10.72 | 10.72 | 30.36 | 7.77 | |
EV/EBIT |
0.00 | — | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 512.03% | |
Price to Operating Income |
0.00 | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
8.21 | 5.92 | 9.57 | 11.45 | |
Average Payables |
2.43 | 6.23 | 5.03 | 3.45 | |
Average Inventory |
0.38 | — | 0.40 | 0.31 | |
Average Assets |
45.83 | 49.21 | 40.57 | 36.33 | |
Average Common Equity |
21.99 | 38.90 | 30.22 | 18.17 |
Columns are period end dates